Skip to main content
OpenTrials

Clinical trial condition

Endometrial Cancer

Explore clinical trials studying Endometrial Cancer. Study availability and eligibility vary by location and protocol.

632 public trials 197 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Cancer trial results

Completed

Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer

NCT00003267

Conditions
Cervical Cancer, Endometrial Cancer, Endometrial Neoplasms, +22 more
Locations
  • Kaiser Franz Josef Hospital Vienna (Wien), Austria
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Gustave Roussy Villejuif, France
View all 18 locations
View Trial Details
Completed

Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

NCT00267488

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • GSK Investigational Site La Jolla, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Engelwood, Colorado, United States
View all 24 locations
View Trial Details
Completed

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

NCT00003127

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • MBCCOP - University of South Alabama Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 94 locations
View Trial Details
Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

NCT00003669

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Huntington Memorial Hospital Pasadena, California, United States
  • Ellis Fischel Cancer Center - Columbia Columbia, Missouri, United States
  • Washington University Barnard Cancer Center St Louis, Missouri, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer

NCT00607607

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Credit Valley Hospital Mississauga, Ontario, Canada
View Trial Details
Completed

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

NCT00245050

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +34 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Southwest General Health Center Cleveland, Ohio, United States
View Trial Details
Completed

Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors

NCT00569257

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University Hospital "Dr. Georgy Stranski" Pleven, Bulgaria
  • Regional Oncology Hospital Plovdiv Plovdiv, Bulgaria
  • Regional Oncodispensary "M.Markov" Varna, Bulgaria
  • Klinik für Frauenheilkunde und Geburtshilfe, Charité Campus Virchow-Klinikum Berlin, Germany
View all 17 locations
View Trial Details

Related conditions